Literature DB >> 6288733

Direct cytochemical localization of catalytic subunits dissociated from cAMP-dependent protein kinase in Reuber H-35 hepatoma cells. II. Temporal and spatial kinetics.

C V Byus, W H Fletcher.   

Abstract

The activation of cyclic AMP-dependent protein kinase has been found to be the predominant mode by which cyclic AMP (cAMP) leads to alterations of a large variety of cellular functions. The activation of the kinase results in the release of the catalytic subunit which as the free enzyme possesses phosphotransferase activity for a variety of specific protein substrates. Using a sensitive and specific cytofluorometric technique we monitored the appearance of free catalytic subunit in Reuber H35 hepatoma cells in culture after incubation with N6-1'-O-dibutyryl-cyclic AMP (DBcAMP), 8-bromoadenosine-3':5'-cyclic monophosphate (8-BrcAMP), and glucagon. The cytochemical method employs the heat-stable inhibitor of the free catalytic subunit which has been conjugated to fluorescein isothiocyanate (F:PKI) and was validated as described in the companion paper (Fletcher and Byus. 1982. J. Cell Biol. 93:719-726). Here we studied the temporal and spatial kinetics of the free catalytic subunit following activation of cAMP-dependent protein kinase by increasing concentrations of DBcAMP,8-BrcAMP, and glucagon. Under similar conditions protein kinase activation was also assessed biochemically in H35 cell supernatants by assaying the protein kinase activity ratio. Incubation of the hepatoma cells with DBcAMP (0.1 mM) led to an increase in the activity ratio from 0.2 in control cultures to a value of nearly 1.0 within a 1- to 2-h period. During this same period using the F:PKI probe, a significant increase in cytoplasmic and nucleolar fluorescence indicative of the release of the free catalytic subunit was coincidentally observed. In contrast to the rapid appearance of catalytic subunit in the cytoplasm and nucleolus of the cell within 5-15 min of the addition of DBcAMP, discernible nucleoplasmic fluorescence did not occur until after 1 h. H35 cell cultures incubated with 8-BrcAMP (0.01-1.0 mM) exhibited a more rapid activation of the protein kinase measured cytochemically compared to the cells treated with DBcAMP. Cultures incubated with 8-BrcAMP had significantly increased cytoplasmic and nucleolar fluorescence compared to unstimulated cells within 1 min of the addition of the analogue and reached a maximal level within 15 min. By employing a microspectrophotometer a distinct dose-dependent increase in cellular fluorescence (i.e., free catalytic subunit) was observed as the concentration of 8-BrcAMP was increased from 0.01 to 1.0 mM at 1, 5, 15, and 60 min following stimulation. The addition of glucagon (10(-6) M) to the culture also led to the activation of cAMP-dependent protein kinase as determined by an increase in the activity ratio. This increase was paralleled throughout the incubation period by a marked elevation in cytoplasmic and nucleolar fluorescence. The results reported herein suggest that both cyclic nucleotide analogues and a polypeptide hormone lead to the activation of cAMP-dependent protein kinase in similar intracellular compartments in Reuber H35 hepatoma cells...

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288733      PMCID: PMC2112128          DOI: 10.1083/jcb.93.3.727

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  31 in total

1.  Cyclic nucleotides in cultured cells.

Authors:  F J Chlapowski; L A Kelly; R W Butcher
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

2.  Correlation between cAMP, activation of cAMP-dependent protein kinase(s), and rate of glycogenolysis in isolated rat hepatocytes.

Authors:  C V Byus; J S Hayes; K Brendel; D H Russell
Journal:  Life Sci       Date:  1976-08-01       Impact factor: 5.037

Review 3.  Proposed model of major sequential biochemical events of a trophic response.

Authors:  D H Russell; C V Byus; C A Manen
Journal:  Life Sci       Date:  1976-11-01       Impact factor: 5.037

4.  Activation and nuclear translocation of protein kinase during transsynaptic induction of tyrosine 3-monooxygenase.

Authors:  E Costa; A Kurosawa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

5.  Studies on the alpha-andrenergic activation of hepatic glucose output. II. Investigation of the roles of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in the actions of phenylephrine in isolated hepatocytes.

Authors:  A D Cherrington; F D Assimacopoulos; S C Harper; J D Corbin; C R Park; J H Exton
Journal:  J Biol Chem       Date:  1976-09-10       Impact factor: 5.157

6.  Regulation of adenosine 3',5'-monophosphate-dependent protein kinase. I. Preliminary characterization of the adipose tissue enzyme in crude extracts.

Authors:  J D Corbin; T R Soderling; C R Park
Journal:  J Biol Chem       Date:  1973-03-10       Impact factor: 5.157

7.  Nuclear protein kinase activity in glucagon-stimulated perfused rat livers.

Authors:  W K Palmer; M Castagna; D A Walsh
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

8.  Protein kinase translocation following beta-adrenergic receptor activation in C6 glioma cells.

Authors:  J P Schwartz; E Costa
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

9.  Critical controls in the evaluation of cAMP-dependent protein kinase activity ratios as indices of hormonal action.

Authors:  W K Palmer; J M McPherson; D A Walsh
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

10.  Nuclear protein-kinase activity in perfused rat liver stimulated with dibutyryl-adenosine cyclic 3':5'-monophosphate.

Authors:  M Castagna; W K Palmer; D A Walsh
Journal:  Eur J Biochem       Date:  1975-06-16
View more
  11 in total

1.  Dynamics of the distribution of cyclic AMP-dependent protein kinase in living cells.

Authors:  J L Meinkoth; Y Ji; S S Taylor; J R Feramisco
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 2.  Nucleocytoplasmic RNA transport.

Authors:  G A Clawson; C M Feldherr; E A Smuckler
Journal:  Mol Cell Biochem       Date:  1985-07       Impact factor: 3.396

Review 3.  Signal transduction through the cAMP-dependent protein kinase.

Authors:  J L Meinkoth; A S Alberts; W Went; D Fantozzi; S S Taylor; M Hagiwara; M Montminy; J R Feramisco
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

Review 4.  A-kinase anchoring proteins: a key to selective activation of cAMP-responsive events?

Authors:  V M Coghlan; S E Bergeson; L Langeberg; G Nilaver; J D Scott
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

Review 5.  Nuclear protein kinases.

Authors:  H R Matthews; V D Huebner
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

6.  Glucagon resistance of hepatoma cells. Evidence for receptor and post-receptor defects.

Authors:  M Fehlmann; M Crettaz; C R Kahn
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

7.  The connexin43 gap junction protein is phosphorylated by protein kinase A and protein kinase C: in vivo and in vitro studies.

Authors:  Maithili M Shah; Anna-Marie Martinez; William H Fletcher
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

8.  Intracellular distribution of mammalian protein kinase A catalytic subunit altered by conserved Asn2 deamidation.

Authors:  R Pepperkok; A Hotz-Wagenblatt; N König; A Girod; D Bossemeyer; V Kinzel
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

9.  Localization of nuclear subunits of cyclic AMP-dependent protein kinase by the immunocolloidal gold method.

Authors:  M R Kuettel; S P Squinto; J Kwast-Welfeld; G Schwoch; J S Schweppe; R A Jungmann
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

10.  Hormone-induced intercellular signal transfer dissociates cyclic AMP-dependent protein kinase.

Authors:  S A Murray; W H Fletcher
Journal:  J Cell Biol       Date:  1984-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.